SYNBODY BIOTECHNOLOGY

Synbody Biotechnology (SBI) is a start-up biotechnology company based on a powerful synthetic antibody, or "Synbody," technology recently discovered at Arizona State University. Synbodies revolutionize the field of high affinity, high specificity therapeutic agents by creating antibody-like function from small purely synthetic peptides. It is SBI's mission to leverage the Synbody technology to create a pipeline of superior human therapeutics across multiple therapeutic areas. SBI seeks to realize the opportunity for synbodies as human therapeutics through a combined strategy comprising corporate partnerships, out-licensing agreements and in-house development.

#People #Website #More

SYNBODY BIOTECHNOLOGY

Industry:

Biotechnology Health Diagnostics Therapeutics

Founded:

2010-01-01

Address:

Farmington, Connecticut, United States

Country:

United States

Website Url:

http://www.synbodybio.com

Total Employee:

1+

Status:

Closed

Contact:

484-883-9725

Email Addresses:

[email protected]

Total Funding:

750 K USD

Technology used in webpage:

Google Font API Google Analytics Nginx PHP CloudFront Google Analytics Classic Apache 2.2 Nginx 1.16 Google Analytics Anonymize IP DNS.COM

Current Advisors List

daniel-wagner_image

Daniel Wagner Board of Directors @ Synbody Biotechnology
Board_member

Current Employees Featured

chris-diehnelt_image

Chris Diehnelt
Chris Diehnelt Director of Discovery @ Synbody Biotechnology
Director of Discovery

not_available_image

Kevin D. Burroughs
Kevin D. Burroughs VP of Research and Development @ Synbody Biotechnology
VP of Research and Development

Founder

paul-hallenbeck_image

Paul Hallenbeck

Official Site Inspections

http://www.synbodybio.com

Host Informations
Whois Informations

Loading ...

More informations about "Synbody Biotechnology" on Search Engine